Focal adhesion kinase (FAK, also known as PTK2) is a tyrosine kinase that regulates
integrin and growth factor signaling pathways and is involved in the migration, proliferation …

Introduction: Focal adhesion kinase (FAK) is a promising target for the treatment of solid
tumors because its expression has been linked to tumor progression, invasion, and drug …

Introduction: Focal adhesion kinase (FAK) is a non-receptor tyrosine kinase that localizes at
sites of cell adhesion to the extracellular matrix (ECM) and mediates signalling events …

Kinases are the ideal druggable targets for diseases and especially were highlighted on
cancer therapy. Focal adhesion kinase (FAK) is a non-receptor tyrosine kinase and its …

Focal adhesion kinase (FAK) is both a non-receptor tyrosine kinase and an adaptor protein
that primarily regulates adhesion signalling and cell migration, but FAK can also promote …

Focal adhesion kinase (FAK) is a non-receptor tyrosine kinase implicated in cancer
progression, and plays a vital role in integrating environmental signals from growth factors …

FAK is a nonreceptor intracellular tyrosine kinase which plays an important biological
function. Many studies have found that FAK is overexpressed in many human cancer cell …

Despite advances in medical and surgical therapy, cancer kills more than half a million
people in the United States annually, and the majority of these patients succumb to …

FAK, a nonreceptor tyrosine kinase, has been recognized as a novel target class for the
development of targeted anticancer agents. Overexpression of FAK is a common occurrence …

Focal adhesion kinase (FAK) is a nonreceptor intracellular tyrosine kinase that plays an
essential role in cancer cell adhesion, survival, proliferation, and migration through both its …